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1. Introduction
This special issue focuses on the role of complementary
and alternative medicine (CAM) in controlling dyslipidemia. Complementary and alternative medicine (CAM),
also known as nonconventional medicine, includes a wide
and heterogeneous array of health care practices (such as
herbal medicine, acupuncture, yoga, meditation, and homeopathic medicine) that are not part of a health care system.
The popularity of CAM has dramatically increased in
many developed countries since the 1990s. This could be
attributed to the aging of population, prevalence of chronic
diseases, and concern about the adverse reaction of chemical
drugs. All these aspects have contributed greatly to the worldwide popularity of CAM. In the United States, consumers
spend over $34 billion per year on CAM therapies spent
outside the conventional health care financing system. This
out-of-pocket expenditure is evidence of the belief that CAM
therapies have benefits that outweigh their costs. CAM is generally more popular in most developed countries, especially
in North America, Europe, and Australia. According to the
2007 National Health Interview Survey on more than 32,800
Americans, 38.2% of adults and 12% of children used some
form of CAM within the previous 12 months.
Dyslipidemia is an independent preventable risk factor
of coronary heart disease and has been shown to increase
the risk of cardiovascular mortality manyfold. Therefore, the
study on various indicators and risk factors of dyslipidemia
appears to be significant for future health outcomes. It is
critically important to recognize the need for treatment of

dyslipidemia and to institute necessary therapies to reduce
the long-term risks of disease recurrence or modify the
metabolic derangements that promote atherosclerosis. Drugs
used in dyslipidemia may cause adverse effects if used for
longer duration. Therefore patients use CAM to reduce lipids
without any major side effect.
The exact reasons for the popularity of CAM are complex;
as they change with time and space, they vary from individual
to individual and from therapy to therapy. In general, there
are a broad range of positive motivations to the present
popularity of CAM.
Although the use and expenditure of CAM have been
increased radically, the potential role of CAM in modern
clinical practice and health care system seems to be limited.
As the efficacy and safety have been the major concerns in the
recognition of CAM and integrating it into the conventional
medicine, hence, there is an urgent need to provide evidence
regarding the merits of the numerous techniques of CAM.
The best way to achieve this is through rigorous research.
Since then, in CAM, simple answers or broad generalizations
are not possible. Each of the numerous techniques has to be
evaluated separately. It is necessary to bring the practice of
CAM in line with evidence. The wide dissemination of its
findings is also important to include CAM into the modern
clinical practice.
Studies have reported that CAM can be ineffective for
a specific condition, but still they could be used as they do
not harm the patients. Some argue that CAM should be used
regardless of the results of placebo-controlled clinical trials,
particularly when its use is not associated with serious risks.
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The main purpose of this issue is to illustrate the
inevitability of researches in the field of CAM to integrate it
into the modern clinical practice. Altogether, 14 manuscripts
were submitted for publication, out of which 11 manuscripts
got accepted. The articles in this issue represent a wide
range of therapeutic approaches of CAM in preventing
dyslipidemia.
This special issue includes a review that discusses the
progress and perspective of studies on dyslipidemia with
single Chinese herb and its monomers or effective extracts
during the past 10 years. The review concludes that traditional
Chinese medicine (TCM) has some beneficial effects on the
treatment of patients with dyslipidemia and has less adverse
effects as compared to chemical agents. However, future
clinical trials are needed to be confirmed about the effects of
TCM.
This edition also includes a randomized, double-blind,
placebo-controlled clinical trial on 50 hyperlipidemic
patients. The results of this trial show that daily consumption
of the fruit extract of Vaccinium arctostaphylos significantly
reduces the serum levels of total cholesterol, LDL-C, and
triglyceride (TG) and oxidative stress in hyperlipidemic
patients. Therefore, this extract could be considered as a
potential agent for treatment of dyslipidemia.
Another study in this issue is on Chaihu-Shugan-San
(CSS), an ancient classical formula composed of seven Chinese herbs, which found that integrated recipe might work
as a significant anti-inflammatory effect in Kupffer cells. In
addition, another study conducted by Han et al. on the
molecular docking of echinocystic acid (EA) (isolated from
G. sinensis fruits) and the effects of it on the possible targets
in in vitro rat liver microsomes has been added.
This review also includes a research paper which concluded that preventive acupuncture and moxibustion can
significantly decrease the plasma TG and LDL, increase
the plasma HDL, and prevent fat accumulation during
climacteric period in rats. Moreover, a paper included is on
intestinal transportations of main chemical compositions of
Polygoni Multiflori Radix (PMR, originated from the root of
Polygonum multiflorum Thunb.). This has been used in the
treatment of hyperlipidemia in some countries for centuries.
Another paper using the same herb PMR has been added
to this special issue which discusses the mechanisms of
the water extracts of Polygoni Multiflori Radix (PMR) and
its processed products (PMRP) on liver lipid metabolism.
Moreover, another paper was included in this review on
propolis, which is a brownish resinous material collected by
worker bees from the leaf buds of numerous plants that have
strong pharmacological and biological properties.
Another study analyzed the effects of acupuncture on
interleukin, IL-17expression in fat excess liver on adult mice,
and provided some basic evidences that the inflammatory
damage of hyperlipidemic fatty liver could be restricted
through acupuncture. A study in this review investigates the
beneficial effects of ethanol extract of Gastrodia elata Blume
(EGB) on lipid metabolism and endothelial dysfunction in a
high-fructose (HF) diet animal model.
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2. Conclusion
The articles included in this issue highlight the need of
sufficient scientific evidence from CAM research to clarify
their mechanism of action and demonstrate their efficacy
and safety. Patients and health care providers need to know
which forms are safe and effective through unbiased scientific
evaluation. Through the rigorous researches, the benefits of
CAM therapies will be highlighted, and this will help in
integration of CAM into the mainstream medicine. This
integrative approach will ultimately lead to a safer and more
effective patient-centered health care system.
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